U.S. Health Care REITs Stock News

The Morning Bull - US Market Morning Update Tuesday, Mar, 24 2026 US stock futures are slightly softer this morning, with key contracts on the S&P 500 and Dow fractionally in the red, as investors weigh mixed global growth signals against stubborn cost pressures. In Europe, Germany's manufacturing PMI sits at 51.7 and France's composite PMI at 48.3, sending a split message where factory activity in one major economy holds up while its neighbor struggles. At the same time, US data shows...

One thing we could say about the analysts on Qfin Holdings, Inc. ( NASDAQ:QFIN ) - they aren't optimistic, having just...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Bally's (BALY) FY 2025 earnings snapshot Bally's (BALY) latest FY 2025 update centers on Q3 numbers, with revenue of US$663.7 million, a basic EPS loss of US$1.70, and net income loss of US$102.9 million as the company continues to operate in the red. Over recent quarters, revenue has ranged from US$580.4 million in Q4 2024 to US$663.7 million in Q3 2025, while quarterly basic EPS has moved between a loss of US$0.30 and a loss of US$5.10, underscoring pressure on profitability. For investors,...

Idaho Strategic Resources (IDR) has put up another solid set of numbers for FY 2025 so far, with third quarter revenue at about US$11.1 million, basic EPS of US$0.20 and trailing 12 month EPS of US$0.73 underpinning net income of US$10.27 million over the past year. The company has seen revenue step up from US$6.2 million in Q2 FY 2024 to US$7.6 million in Q4 FY 2024 and then to US$11.1 million in Q3 FY 2025. Quarterly basic EPS moved from US$0.17 to US$0.18 and now just over US$0.20, setting...

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...

What the Emburse and DocuSign expansions mean for Dayforce stock Dayforce (DAY) has broadened its relationships with Emburse and DocuSign, folding expense management and digital agreement tools more tightly into its HCM platform through certified integrations and a reseller model. For you as an investor, this move centers on two practical ideas: Dayforce aiming to keep more of a customer’s HR workflow inside its own ecosystem, and partners gaining distribution through Dayforce’s channel. See...

If you are wondering whether Pharvaris at around US$26 a share still offers value, it helps to step back and look at what the recent returns and current valuation are really telling you. The stock has delivered a 68.8% return over the past year and a very large 3 year gain of around 3.5x, even though the year to date return is a 1.8% decline and the 30 day return is a 7.5% decline. This can change how the risk and reward balance feels right now. Recent headlines around Pharvaris have focused...

Coastal Financial (NasdaqGS:CCB) has appointed Jeffrey M. Chapman, a banking technology veteran with over 25 years of experience, to its Board of Directors. Chapman will serve on the Technology and CCBX Oversight Committees, with the appointment highlighting a focus on digital banking and platform development. Coastal Financial, trading at $74.36, has seen a mixed share price record, with a 103.6% return over 3 years and a 176.9% return over 5 years, alongside a 34.4% decline year to date...

SWK Holdings (SWKH) closed out FY 2025 with fourth quarter revenue of US$6.6 million and a basic EPS loss of US$1.60, compared with revenue of US$9.2 million and basic EPS of US$0.48 in the same quarter a year earlier. The trailing twelve month EPS came in at a loss of US$0.21 on revenue of US$37.6 million. Over recent quarters, revenue has moved from US$9.2 million in Q4 2024 to US$12.2 million in Q1 2025, US$8.1 million in Q2 2025 and US$10.6 million in Q3 2025. Basic EPS shifted from...

Wondering whether GeneDx Holdings at around US$69.84 is a bargain or already pricing in a lot of optimism? This article walks through what the numbers currently say about value. The stock has had a choppy run, with a 10.2% decline over the last 7 days, a 14.9% decline over the last 30 days, a 47.2% decline year to date, a very large 3 year return, and a 33.1% decline over the last year. These swings have kept GeneDx on the radar for investors watching for changing expectations and risk...

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...

Wondering if Alliant Energy’s current share price reflects its real worth, or if you might be paying too much for a regulated utility stock right now? The stock last closed at US$68.71, with a 7 day return of a 5.6% decline, a 30 day return of a 1.2% decline, a 1 year return of 12.5%, a 3 year return of 46.9%, and a 5 year return of 49.7%. These moves have come as investors continue to reassess regulated utilities as an income and stability option. Alliant Energy has attracted attention as...

Aveanna Healthcare Holdings (NasdaqGS:AVAH) announced the acquisition of Family First Homecare. The deal is intended to strengthen Aveanna's position in Florida and widen its geographic reach. The company also outlined a transformation that increased preferred payer agreements and set new M&A priorities for 2026. Aveanna Healthcare focuses on home based care services, an area many investors watch as care delivery shifts closer to the home. By adding Family First Homecare, the company is...

If you are wondering whether Enerpac Tool Group at around US$35.97 is a bargain, fairly priced, or looking stretched, this article walks through the key valuation angles to help you frame that question clearly. The stock is roughly flat over the last week with a 0.3% return. That sits against a 14.7% decline over the last month and a 14.8% decline over the last year, even as the 3 year and 5 year returns are 37.7% and 38.0% respectively. Recent coverage has focused on how Enerpac Tool Group...

Wondering if Rezolve AI at US$2.53 is still priced for a turnaround or already baking in the story? This breakdown will help you frame what the current market price may be implying. The stock has been volatile recently, with a 5.9% decline over the last week, a 13.5% gain over the last month, an 11.8% year to date drop, and a 53.3% return over the past year, all set against a 74.9% decline over three years. Recent coverage has focused on Rezolve AI as an emerging player in the listed AI...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...